The DOI matches its Crossref record; 103 of the 103 references it cites were found in a registry or an index.
Amyotrophic Lateral Sclerosis: An Update for 2018
Abstract
&NA; Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease affecting motor neurons and other neuronal cells, leading to severe disability and eventually death from ventilatory failure. It has a prevalence of 5 in 100,000, with an incidence of 1.7 per 100,000, reflecting short average survival. The pathogenesis is incompletely understood, but defects of RNA processing and protein clearance may be fundamental. Repeat expansions in the chromosome 9 open reading frame 72 gene (C9orf72) are the most common known genetic cause of ALS and are seen in approximately 40% of patients with a family history and approximately 10% of those without. No environmental risk factors are proved to be causative, but many have been proposed, including military service. The diagnosis of ALS rests on a history of painless progressive weakness coupled with examination findings of upper and lower motor dysfunction. No diagnostic test is yet available, but electromyography and genetic tests can support the diagnosis. Care for patients is best provided by a multidisciplinary team, and most interventions are directed at managing symptoms. Two medications with modest benefits have Food and Drug Administration approval for the treatment of ALS: riluzole, a glutamate receptor antagonist, and, new in 2017, edaravone, a free radical scavenger. Many other encouraging treatment strategies are being explored in clinical trials for ALS; herein we review stem cell and antisense oligonucleotide gene therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
Neumann, M., Sampathu, D. M., Kwong, L. K., Truax, A. C., Micsenyi, M. C., Chou, T. T., Bruce, J., Schuck, T., Grossman, M., Clark, C. M., et al. (2006) · Science · doi:10.1126/science.1134108 · Cited by 6,576
DeJesus-Hernandez, M., Mackenzie, I. R., Boeve, B. F., Boxer, A. L., Baker, M., Rutherford, N. J., Nicholson, A. M., Finch, N. A., Flynn, H., Adamson, J., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.011 · Cited by 4,936
A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD
Renton, A. E., Majounie, E., Waite, A., Simón-Sánchez, J., Rollinson, S., Gibbs, J. R., Schymick, J. C., Laaksovirta, H., van Swieten, J. C., Myllykangas, L., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.010 · Cited by 4,409
A perivascular origin for mesenchymal stem cells in multiple human organs
Crisan, M., Yap, S., Casteilla, L., Chen, C.-W., Corselli, M., Park, T. S., Andriolo, G., Sun, B., Zheng, B., Zhang, L., et al. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.07.003 · Cited by 3,991
Arai, T., Hasegawa, M., Akiyama, H., Ikeda, K., Nonaka, T., Mori, H., Mann, D., Tsuchiya, K., Yoshida, M., Hashizume, Y., et al. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.10.093 · Cited by 2,732
TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis
Sreedharan, J., Blair, I. P., Tripathi, V. B., Hu, X., Vance, C., Rogelj, B., Ackerley, S., Durnall, J. C., Williams, K. L., Buratti, E., et al. (2008) · Science · doi:10.1126/science.1154584 · Cited by 2,630
A Controlled Trial of Riluzole in Amyotrophic Lateral Sclerosis
Bensimon, G., Lacomblez, L., & Meininger, V. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403033300901 · Cited by 2,233
Converging Mechanisms in ALS and FTD: Disrupted RNA and Protein Homeostasis
Ling, S.-C., Polymenidou, M., & Cleveland, D. W. (2013) · Neuron · doi:10.1016/j.neuron.2013.07.033 · Cited by 1,811
TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis
Kabashi, E., Valdmanis, P. N., Dion, P., Spiegelman, D., McConkey, B. J., Velde, C. V., Bouchard, J.-P., Lacomblez, L., Pochigaeva, K., Salachas, F., et al. (2008) · Nature Genetics · doi:10.1038/ng.132 · Cited by 1,544
Dose-ranging study of riluzole in amyotrophic lateral sclerosis
Amyotrophic Lateral Sclerosis/Riluzole Study Group II, Lacomblez, L., Bensimon, G., Meininger, V, Leigh, P. N., & Guillet, P. (1996) · The Lancet · doi:10.1016/s0140-6736(96)91680-3 · Cited by 1,301
Mutations of optineurin in amyotrophic lateral sclerosis
Maruyama, H., Morino, H., Ito, H., Izumi, Y., Kato, H., Watanabe, Y., Kinoshita, Y., Kamada, M., Nodera, H., Suzuki, H., et al. (2010) · Nature · doi:10.1038/nature08971 · Cited by 1,265
Exome Sequencing Reveals VCP Mutations as a Cause of Familial ALS
Johnson, J. O., Mandrioli, J., Benatar, M., Abramzon, Y., Van Deerlin, V. M., Trojanowski, J. Q., Gibbs, J. R., Brunetti, M., Gronka, S., Wuu, J., et al. (2010) · Neuron · doi:10.1016/j.neuron.2010.11.036 · Cited by 1,235
Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia
Deng, H.-X., Chen, W., Hong, S.-T., Boycott, K. M., Gorrie, G. H., Siddique, N., Yang, Y., Fecto, F., Shi, Y., Zhai, H., et al. (2011) · Nature · doi:10.1038/nature10353 · Cited by 1,174
The EFNS Task Force on Diagnosis and Management of Amyotrophic Lateral Sclerosis:, Andersen, P. M., Abrahams, S., Borasio, G. D., de Carvalho, M., Chio, A., Van Damme, P., Hardiman, O., Kollewe, K., Morrison, K. E., et al. (2012) · European Journal of Neurology · doi:10.1111/j.1468-1331.2011.03501.x · Cited by 1,117
Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways
Cirulli, E. T., Lasseigne, B. N., Petrovski, S., Sapp, P. C., Dion, P. A., Leblond, C. S., Couthouis, J., Lu, Y.-F., Wang, Q., Krueger, B. J., et al. (2015) · Science · doi:10.1126/science.aaa3650 · Cited by 966
Karussis, D., Karageorgiou, C., Vaknin-Dembinsky, A., Gowda-Kurkalli, B., Gomori, J. M., Kassis, I., Bulte, J. W. M., Petrou, P., Ben-Hur, T., Abramsky, O., et al. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.248 · Cited by 941
Abe, K., Aoki, M., Tsuji, S., Itoyama, Y., Sobue, G., Togo, M., Hamada, C., Tanaka, M., Akimoto, M., Nakamura, K., et al. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30115-1 · Cited by 935
The epidemiology of ALS: a conspiracy of genes, environment and time
Al-Chalabi, A., & Hardiman, O. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.203 · Cited by 894
Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia
Skibinski, G., Parkinson, N. J., Brown, J. M., Chakrabarti, L., Lloyd, S. L., Hummerich, H., Nielsen, J. E., Hodges, J. R., Spillantini, M. G., Thusgaard, T., et al. (2005) · Nature Genetics · doi:10.1038/ng1609 · Cited by 822
Miller, R. G., Jackson, C. E., Kasarskis, E. J., England, J. D., Forshew, D., Johnston, W., Kalra, S., Katz, J. S., Mitsumoto, H., Rosenfeld, J., et al. (2009) · Neurology · doi:10.1212/wnl.0b013e3181bc0141 · Cited by 807
Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia
Freischmidt, A., Wieland, T., Richter, B., Ruf, W., Schaeffer, V., Müller, K., Marroquin, N., Nordin, F., Hübers, A., Weydt, P., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.4000 · Cited by 786
Van Deerlin, V. M., Leverenz, J. B., Bekris, L. M., Bird, T. D., Yuan, W., Elman, L. B., Clay, D., Wood, E. M., Chen-Plotkin, A. S., Martinez-Lage, M., et al. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70071-1 · Cited by 723
Current hypotheses for the underlying biology of amyotrophic lateral sclerosis
Rothstein, J. D. (2009) · Annals of Neurology · doi:10.1002/ana.21543 · Cited by 703
C9orf72 Dipeptide Repeats Impair the Assembly, Dynamics, and Function of Membrane-Less Organelles
Lee, K.-H., Zhang, P., Kim, H. J., Mitrea, D. M., Sarkar, M., Freibaum, B. D., Cika, J., Coughlin, M., Messing, J., Molliex, A., et al. (2016) · Cell · doi:10.1016/j.cell.2016.10.002 · Cited by 684
Miller, R. G., Jackson, C. E., Kasarskis, E. J., England, J. D., Forshew, D., Johnston, W., Kalra, S., Katz, J. S., Mitsumoto, H., Rosenfeld, J., et al. (2009) · Neurology · doi:10.1212/wnl.0b013e3181bc01a4 · Cited by 674
<emph type="ital">SQSTM1</emph> Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis
Fecto, F. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.250 · Cited by 650
Mackenzie, I. R., Nicholson, A. M., Sarkar, M., Messing, J., Purice, M. D., Pottier, C., Annu, K., Baker, M., Perkerson, R. B., Kurti, A., et al. (2017) · Neuron · doi:10.1016/j.neuron.2017.07.025 · Cited by 640
TDP‐43 A315T mutation in familial motor neuron disease
Gitcho, M. A., Baloh, R. H., Chakraverty, S., Mayo, K., Norton, J. B., Levitch, D., Hatanpaa, K. J., White, C. L., Bigio, E. H., Caselli, R., et al. (2008) · Annals of Neurology · doi:10.1002/ana.21344 · Cited by 619
Miller, T. M., Pestronk, A., David, W., Rothstein, J., Simpson, E., Appel, S. H., Andres, P. L., Mahoney, K., Allred, P., Alexander, K., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70061-9 · Cited by 617
C9orf72 is required for proper macrophage and microglial function in mice
O’Rourke, J. G., Bogdanik, L., Yáñez, A., Lall, D., Wolf, A. J., Muhammad, A. K. M. G., Ho, R., Carmona, S., Vit, J. P., Zarrow, J., et al. (2016) · Science · doi:10.1126/science.aaf1064 · Cited by 550
Jiang, J., Zhu, Q., Gendron, T. F., Saberi, S., McAlonis-Downes, M., Seelman, A., Stauffer, J. E., Jafar-nejad, P., Drenner, K., Schulte, D., et al. (2016) · Neuron · doi:10.1016/j.neuron.2016.04.006 · Cited by 536
Self-citationWen, X., Tan, W., Westergard, T., Krishnamurthy, K., Markandaiah, S. S., Shi, Y., Lin, S., Shneider, N. A., Monaghan, J., Pandey, U. B., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.12.010 · Cited by 527
Prevalence of Amyotrophic Lateral Sclerosis — United States, 2014
Mehta, P., Kaye, W., Raymond, J., Wu, R., Larson, T., Punjani, R., Heller, D., Cohen, J., Peters, T., Muravov, O., et al. (2018) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6707a3 · Cited by 458
Novel Mutations in TARDBP (TDP-43) in Patients with Familial Amyotrophic Lateral Sclerosis
Rutherford, N. J., Zhang, Y.-J., Baker, M., Gass, J. M., Finch, N. A., Xu, Y.-F., Stewart, H., Kelley, B. J., Kuntz, K., Crook, R. J. P., et al. (2008) · PLoS Genetics · doi:10.1371/journal.pgen.1000193 · Cited by 455
ALS clinical trials review: 20 years of failure. Are we any closer to registering a new treatment?
Petrov, D., Mansfield, C., Moussy, A., & Hermine, O. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00068 · Cited by 451
ALS phenotypes with mutations in CHMP2B (charged multivesicular body protein 2B)
Parkinson, N., Ince, P. G., Smith, M. O., Highley, R., Skibinski, G., Andersen, P. M., Morrison, K. E., Pall, H. S., Hardiman, O., Collinge, J., et al. (2006) · Neurology · doi:10.1212/01.wnl.0000231510.89311.8b · Cited by 395
Mechanistic insights into mammalian stress granule dynamics
Panas, M. D., Ivanov, P., & Anderson, P. (2016) · Journal of Cell Biology · doi:10.1083/jcb.201609081 · Cited by 374
TDP ‐ 43 mutation in familial amyotrophic lateral sclerosis
Yokoseki, A., Shiga, A., Tan, C., Tagawa, A., Kaneko, H., Koyama, A., Eguchi, H., Tsujino, A., Ikeuchi, T., Kakita, A., et al. (2008) · Annals of Neurology · doi:10.1002/ana.21392 · Cited by 373
Abe, K., Itoyama, Y., Sobue, G., Tsuji, S., Aoki, M., Doyu, M., Hamada, C., Kondo, K., Yoneoka, T., Akimoto, M., et al. (2014) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2014.959024 · Cited by 365
Charcot, J. M. (1869) · Medical Entomology and Zoology · Cited by 321
hnRNP A1 Relocalization to the Stress Granules Reflects a Role in the Stress Response
Guil, S., Long, J. C., & Cáceres, J. F. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00224-06 · Cited by 319
Petrou, P., Gothelf, Y., Argov, Z., Gotkine, M., Levy, Y. S., Kassis, I., Vaknin-Dembinsky, A., Ben-Hur, T., Offen, D., Abramsky, O., et al. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2015.4321 · Cited by 303
Gendron, T. F., Chew, J., Stankowski, J. N., Hayes, L. R., Zhang, Y.-J., Prudencio, M., Carlomagno, Y., Daughrity, L. M., Jansen-West, K., Perkerson, E. A., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aai7866 · Cited by 265
Self-citationMechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease
Radunovic, A., Annane, D., Rafiq, M. K., Brassington, R., & Mustfa, N. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004427.pub4 · Cited by 238
Tao, Z., Wang, H., Xia, Q., Li, K., Li, K., Jiang, X., Xu, G., Wang, G., & Ying, Z. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv005 · Cited by 236
The course of the terminal phase in patients with amyotrophic lateral sclerosis
Neudert, C., Oliver, D., Wasner, M., & Borasio, G. D. (2001) · Journal of Neurology · doi:10.1007/s004150170140 · Cited by 233
A Review of Spasticity Treatments: Pharmacological and Interventional Approaches
Chang, E., Ghosh, N., Yanni, D., Lee, S., Alexandru, D., & Mozaffar, T. (2013) · Critical Reviews in Physical and Rehabilitation Medicine · doi:10.1615/critrevphysrehabilmed.2013007945 · Cited by 233
Feldman, E. L., Boulis, N. M., Hur, J., Johe, K., Rutkove, S. B., Federici, T., Polak, M., Bordeau, J., Sakowski, S. A., & Glass, J. D. (2014) · Annals of Neurology · doi:10.1002/ana.24113 · Cited by 227
Gao, F., Almeida, S., & Lopez‐Gonzalez, R. (2017) · The EMBO Journal · doi:10.15252/embj.201797568 · Cited by 218
High frequency of TARDBP gene mutations in Italian patients with amyotrophic lateral sclerosis
Corrado, L., Ratti, A., Gellera, C., Buratti, E., Castellotti, B., Carlomagno, Y., Ticozzi, N., Mazzini, L., Testa, L., Taroni, F., et al. (2009) · Human Mutation · doi:10.1002/humu.20950 · Cited by 207
Amyotrophic lateral sclerosis in Olmsted County, Minnesota, 1925 to 1998
Sorenson, E. J., Stalker, A. P., Kurland, L. T., & Windebank, A. J. (2002) · Neurology · doi:10.1212/wnl.59.2.280 · Cited by 205
Mesenchymal stromal cell transplantation in amyotrophic lateral sclerosis: a long-term safety study
Mazzini, L., Mareschi, K., Ferrero, I., Miglioretti, M., Stecco, A., Servo, S., Carriero, A., Monaco, F., & Fagioli, F. (2012) · Cytotherapy · doi:10.3109/14653249.2011.613929 · Cited by 205
Human neural stem cell transplantation in ALS: initial results from a phase I trial
Mazzini, L., Gelati, M., Profico, D., Sgaravizzi, G., Projetti Pensi, M., Muzi, G., Ricciolini, C., Rota Nodari, L., Carletti, S., Giorgi, C., et al. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-014-0371-2 · Cited by 205
Contribution of TARDBP mutations to sporadic amyotrophic lateral sclerosis
Daoud, H., Valdmanis, P. N., Kabashi, E., Dion, P., Dupré, N., Camu, W., Meininger, V, & Rouleau, G. A. (2009) · Journal of Medical Genetics · doi:10.1136/jmg.2008.062463 · Cited by 194
Oligodendrocytes contribute to motor neuron death in ALS via SOD1-dependent mechanism
Ferraiuolo, L., Meyer, K., Sherwood, T. W., Vick, J., Likhite, S., Frakes, A., Miranda, C. J., Braun, L., Heath, P. R., Pineda, R., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1607496113 · Cited by 189
Implications of ALS focality: Rostral–caudal distribution of lower motor neuron loss postmortem
Ravits, J., Laurie, P., Fan, Y., & Moore, D. H. (2007) · Neurology · doi:10.1212/01.wnl.0000261045.57095.56 · Cited by 181
Oh, K.-W., Moon, C., Kim, H. Y., Oh, S.-I., Park, J., Lee, J. H., Chang, I. Y., Kim, K. S., & Kim, S. H. (2015) · Stem Cells Translational Medicine · doi:10.5966/sctm.2014-0212 · Cited by 180
Microglia and C9orf72 in neuroinflammation and ALS and frontotemporal dementia
Lall, D., & Baloh, R. H. (2017) · Journal of Clinical Investigation · doi:10.1172/jci90607 · Cited by 175
Berlowitz, D. J., Howard, M. E., Fiore, J. F., Hoorn, S. V., O’Donoghue, F. J., Westlake, J., Smith, A. M., Beer, F., Mathers, S., & Talman, P. S. (2015) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2014-310055 · Cited by 170
Model-Based Recursive Partitioning for Subgroup Analyses
Seibold, H., Zeileis, A., & Hothorn, T. (2016) · The International Journal of Biostatistics · doi:10.1515/ijb-2015-0032 · Cited by 167
Autophagy Dysregulation in ALS: When Protein Aggregates Get Out of Hand
Ramesh, N., & Pandey, U. B. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00263 · Cited by 163
Enteral tube feeding for amyotrophic lateral sclerosis/motor neuron disease
Katzberg, H. D., & Benatar, M. G. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004030.pub3 · Cited by 161
Ayers, J. I., Fromholt, S., O’Neal, V., Diamond, J., & Borchelt, D. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1514-0 · Cited by 161
Two German Kindreds With Familial Amyotrophic Lateral Sclerosis Due to TARDBP Mutations
Kühnlein, P., Sperfeld, A.-D., Vanmassenhove, B., Van Deerlin, V., Lee, V. M.-Y., Trojanowski, J. Q., Kretzschmar, H. A., Ludolph, A. C., & Neumann, M. (2008) · Archives of Neurology · doi:10.1001/archneur.65.9.1185 · Cited by 159
Transplantation of spinal cord–derived neural stem cells for ALS: Analysis of phase 1 and 2 trials
Glass, J. D., Hertzberg, V. S., Boulis, N. M., Riley, J., Federici, T., Polak, M., Bordeau, J., Fournier, C., Johe, K., Hazel, T., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000002889 · Cited by 159
Characterization of the dipeptide repeat protein in the molecular pathogenesis of c9FTD/ALS
Yamakawa, M., Ito, D., Honda, T., Kubo, K., Noda, M., Nakajima, K., & Suzuki, N. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu576 · Cited by 158
Potential Environmental Factors in Amyotrophic Lateral Sclerosis
Oskarsson, B., Horton, D. K., & Mitsumoto, H. (2015) · Neurologic Clinics · doi:10.1016/j.ncl.2015.07.009 · Cited by 156
Self-citationDefining and Diagnosing Involuntary Emotional Expression Disorder
Cummings, J. L., Arciniegas, D. B., Brooks, B. R., Herndon, R. M., Lauterbach, E. C., Pioro, E. P., Robinson, R. G., Scharre, D. W., Schiffer, R. B., & Weintraub, D. A. (2006) · CNS Spectrums · doi:10.1017/s1092852900026614 · Cited by 150
Safety of intrathecal autologous adipose-derived mesenchymal stromal cells in patients with ALS
Staff, N. P., Madigan, N. N., Morris, J. M., Jentoft, M. E., Sorenson, E. J., Butler, G. W., Gastineau, D. A., Dietz, A. B., & Windebank, A. J. (2016) · Neurology · doi:10.1212/wnl.0000000000003359 · Cited by 126
Self-citationTripathi, P., Rodriguez-Muela, N., Klim, J. R., de Boer, A. S., Agrawal, S., Sandoe, J., Lopes, C. S., Ogliari, K. S., Williams, L. A., Shear, M., et al. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.06.008 · Cited by 123
Bo, R. D., Ghezzi, S., Corti, S. P., Pandolfo, M., Ranieri, M., Santoro, D., Ghione, I., Prelle, A. C., Orsetti, V., Mancuso, M., et al. (2009) · European Journal of Neurology · doi:10.1111/j.1468-1331.2009.02574.x · Cited by 122
Disease Mechanisms ofC9ORF72Repeat ExpansionsPreprint
Gendron, T. F., & Petrucelli, L. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a024224 · Cited by 117
Self-citationA randomized trial of mexiletine in ALS
Weiss, M. D., Macklin, E. A., Simmons, Z., Knox, A., Greenblatt, D. J., Atassi, N., Graves, M. C., Parziale, N., Salameh, J. S., Quinn, C. C., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000002507 · Cited by 113
Stress granules at the intersection of autophagy and ALS
Monahan, Z. T., Shewmaker, F. P., & Pandey, U. B. (2016) · Brain Research · doi:10.1016/j.brainres.2016.05.022 · Cited by 111
Prevalence of Amyotrophic Lateral Sclerosis — United States, 2012–2013
Mehta, P., Kaye, W., Bryan, L. N., Larson, T. C., III, Copeland, T. P., Wu, J., Muravov, O. I., & Horton, D. K. (2016) · MMWR Surveillance Summaries · doi:10.15585/mmwr.ss6508a1 · Cited by 110
Estimating daily energy expenditure in individuals with amyotrophic lateral sclerosis
Kasarskis, E. J., Mendiondo, M. S., Matthews, D. E., Mitsumoto, H., Tandan, R., Simmons, Z., Bromberg, M. B., & Kryscio, R. J. (2014) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.069997 · Cited by 105
Meta-analysis of pharmacogenetic interactions in amyotrophic lateral sclerosis clinical trials
van Eijk, R. P. A., Jones, A. R., Sproviero, W., Shatunov, A., Shaw, P. J., Leigh, P. N., Young, C. A., Shaw, C. E., Mora, G., Mandrioli, J., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000004606 · Cited by 102
Gonzalez‐Bermejo, J., Morélot‐Panzini, C., Tanguy, M., Meininger, V., Pradat, P., Lenglet, T., Bruneteau, G., Forestier, N. L., Couratier, P., Guy, N., et al. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)30233-2 · Cited by 100
Review: Transactive response DNA-binding protein 43 (TDP-43): mechanisms of neurodegeneration
Gendron, T. F., Josephs, K. A., & Petrucelli, L. (2010) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2010.01060.x · Cited by 90
Self-citationSupramaximal Inflation Improves Lung Compliance in Subjects With Amyotrophic Lateral Sclerosis
Lechtzin, N., Shade, D. M., Clawson, L., & Wiener, C. M. (2006) · CHEST Journal · doi:10.1378/chest.129.5.1322 · Cited by 88
Sancho, J., Servera, E., Morélot‐Panzini, C., Salachas, F., Similowski, T., & Gonzalez‐Bermejo, J. (2013) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2013.855790 · Cited by 83
Evidence for mast cells contributing to neuromuscular pathology in an inherited model of ALS
Trías, E., Ibarburu, S., Barreto‐Núñez, R., Varela, V., Moura, I. C., Dubreuil, P. C., Hermine, O., Beckman, J. S., & Barbeito, L. (2017) · JCI Insight · doi:10.1172/jci.insight.95934 · Cited by 82
Developing multidisciplinary clinics for neuromuscular care and research
Paganoni, S., Nicholson, K., Leigh, F., Swoboda, K. J., Chad, D. A., Drake, K., Haley, K. E., Cudkowicz, M., & Berry, J. D. (2017) · Muscle & Nerve · doi:10.1002/mus.25725 · Cited by 79
A Review of Options for Treating Sialorrhea in Amyotrophic Lateral Sclerosis
Banfi, P. I., Ticozzi, N., Lax, A., Guidugli, G. A., Nicolini, A., & Silani, V. (2014) · Respiratory Care · doi:10.4187/respcare.02856 · Cited by 77
The evaluation of pain in amyotrophic lateral sclerosis: A case controlled observational study
Wallace, V. C. J., Ellis, C., Burman, R., Knights, C., Shaw, C. E., & Al‐Chalabi, A. (2014) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2014.951944 · Cited by 77
Modafinil to treat fatigue in amyotrophic lateral sclerosis: An open label pilot study
Carter, G. T., Weiss, M. D., Lou, J.-S., Jensen, M. P., Abresch, R. T., Martin, T. K., Hecht, T. W., Han, J. J., Weydt, P., & Kraft, G. H. (2005) · American Journal of Hospice and Palliative Medicine® · doi:10.1177/104990910502200112 · Cited by 75
Vitamin D deficiency and its supplementation in patients with amyotrophic lateral sclerosis
Karam, C., Barrett, M. J., Imperato, T., MacGowan, D. J. L., & Scelsa, S. (2013) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2013.01.011 · Cited by 74
Oskarsson, B., Moore, D. H., Mozaffar, T., Ravits, J., Wiedau‐Pazos, M., Parziale, N., Joyce, N. C., Mandeville, R. M., Goyal, N., Cudkowicz, M., et al. (2018) · Muscle & Nerve · doi:10.1002/mus.26117 · Cited by 60
Self-citationTDP-43 M311V mutation in familial amyotrophic lateral sclerosis
Lemmens, R., Race, V., Hersmus, N., Matthijs, G., Bosch, L. V. D., Damme, P. V., Dubois, B., Boonen, S. E., Goris, A., & Robberecht, W. (2009) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2008.157677 · Cited by 58
Seppanen, E. J., Roy, E., Ellis, R., Bou–Gharios, G., Fisk, N. M., & Khosrotehrani, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062662 · Cited by 55
Experience with telemedicine in a multi-disciplinary ALS clinic
van de Rijn, M., Paganoni, S., Levine, M., Campbell, K., Ellrodt, A. S., Estrada, J., Cohen, A. B., Schwamm, L. H., & Berry, J. D. (2017) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2017.1392577 · Cited by 53
Depression and anxiety in individuals with amyotrophic lateral sclerosis: a systematic review
Carvalho, T. L., de Almeida, L. M. S., Lorega, C. M. A., Barata, M. F. O., Ferreira, M. L. B., de Brito-Marques, P. R., & Correia, C. D. C. (2016) · Trends in Psychiatry and Psychotherapy · doi:10.1590/2237-6089-2015-0030 · Cited by 52
Laughter, crying and sadness in ALS
Thakore, N. J., & Pioro, E. P. (2017) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2017-315622 · Cited by 49
Marin, B., Arcuti, S., Jesus, P., Logroscino, G., Copetti, M., Fontana, A., Nicol, M., Raymondeau, M., Desport, J. C., Preux, P. M., et al. (2016) · Neurodegenerative Diseases · doi:10.1159/000442444 · Cited by 48
Complementary and Alternative Therapies in Amyotrophic Lateral Sclerosis
Bedlack, R., Joyce, N. C., Carter, G. T., Paganoni, S., & Karam, C. (2015) · Neurologic Clinics · doi:10.1016/j.ncl.2015.07.008 · Cited by 47
Nicholson, T. T., Smith, S. B., Siddique, T., Sufit, R. L., Ajroud‐Driss, S., Coleman, J. M., & Wolfe, L. F. (2017) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201605-346oc · Cited by 45
McGeachan, A. J., Hobson, E., Al‐Chalabi, A., Stephenson, J., Chandran, S., Crawley, F., Dick, D. J., Donaghy, C. G., Ellis, C., Gorrie, G., et al. (2016) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2016.1221433 · Cited by 44
Death with dignity in Washington patients with amyotrophic lateral sclerosis
Wang, L. H., Elliott, M. A., Henson, L. J., Gerena-Maldonado, E., Strom, S., Downing, S., Vetrovs, J., Kayihan, P., Paul, P., Kennedy, K. J., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000003335 · Cited by 40
Current Concepts in the Pharmacotherapy of Pseudobulbar Affect
Pioro, E. P. (2011) · Drugs · doi:10.2165/11591450-000000000-00000 · Cited by 38
Functional Decline is Associated with Hopelessness in Amyotrophic Lateral Sclerosis (ALS)
Paganoni, S., McDonnell, E., Schoenfeld, D., Yu, H., Deng, J., Atassi, H. A., Sherman, A., Yerramilli-Rao, P., Cudkowicz, M., & Atassi, N. (2017) · Journal of Neurology & Neurophysiology · doi:10.4172/2155-9562.1000423 · Cited by 37
Vitamin D levels are associated with gross motor function in amyotrophic lateral sclerosis
Paganoni, S., Macklin, E. A., Karam, C., Yu, H., Gonterman, F., Fetterman, K. A., Cudkowicz, M., Berry, J. D., & Wills, A.-M. A. (2017) · Muscle & Nerve · doi:10.1002/mus.25555 · Cited by 25
Rare combination of myasthenia and motor neuronopathy, responsive to Msc‐Ntf stem cell therapy
Petrou, P., Argov, A., Lennon, V. A., Gotkine, M., Kassis, I., Vaknin‐Dembinsky, A., Ben‐Hur, T., Offen, D., Abramsky, O., Melamed, E., et al. (2013) · Muscle & Nerve · doi:10.1002/mus.24143 · Cited by 19
Genome editing technologies and their potential to treat neurologic disease
Madigan, N. N., Staff, N. P., Windebank, A. J., & Benarroch, E. E. (2017) · Neurology · doi:10.1212/wnl.0000000000004558 · Cited by 7
Self-citation
Cited by
Trial of Sodium Phenylbutyrate–Taurursodiol for Amyotrophic Lateral Sclerosis
Paganoni, S., Macklin, E. A., Hendrix, S., Berry, J. D., Elliott, M. A., Maiser, S., Karam, C., Caress, J. B., Owegi, M. A., Quick, A., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1916945 · Cited by 536
Mesenchymal Stromal Cell Therapies for Neurodegenerative Diseases
Staff, N. P., Jones, D. T., & Singer, W. (2019) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2019.01.001 · Cited by 150
Self-citationRisk factors and emerging therapies in amyotrophic lateral sclerosis
Nowicka, N., Juranek, J., Juranek, J. K., & Wojtkiewicz, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112616 · Cited by 106
Current Concepts on Genetic Aspects of Mitochondrial Dysfunction in Amyotrophic Lateral Sclerosis
Jankovic, M., Novakovic, I., Gamil Anwar Dawod, P., Gamil Anwar Dawod, A., Drinic, A., Abdel Motaleb, F. I., Ducic, S., & Nikolic, D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189832 · Cited by 36
Cristofani, R., Rusmini, P., Galbiati, M., Cicardi, M. E., Ferrari, V., Tedesco, B., Casarotto, E., Chierichetti, M., Messi, E., Piccolella, M., et al. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00796 · Cited by 35
Metadata
- Authors
- Oskarsson, B., Gendron, T. F., & Staff, N. P.
- Venue
- Mayo Clinic Proceedings
- Publisher
- Elsevier BV
- Published
- 2018-11
- Volume
- 93
- Issue
- 11
- Pages
- 1617-1628
- ISSN
- 0025-6196 (ISSN-L)
- OpenAlex
- W2810654871
- Cited by
- 316
- References
- 103
- FWCI
- 19.71
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.